Stuart Therapeutics Inc., a company developing peptide therapeutics for ophthalmic disease, has completed an $11 million series A financing led by Infocus Capital Partners, an ophthalmology-focused life sciences venture capital fund, with significant participation by the Wisconsin Alumni Research Foundation, Mimo Capital and Biobrit.
'Things are good': Experts express optimism about #Madison's #economy. http://ow.ly/GiTE50LUItt via @NatalieYahr @CapTimes
.@BellinHealth + @gundersenhealth complete merger. http://ow.ly/EA2l50LUIGl via @LaCrosseTribune #Wisconsin #healthcare
The downward trend in southeastern #Wisconsin #manufacturing activity continued through November.
http://ow.ly/Fv7z50LUIEx via @BizTimesMedia